- Home
- GTBP vs FTFT Comparison
GTBP vs FTFT Comparison
Compare GTBP & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- FTFT
- Stock Information
- Founded
- GTBP 1965
- FTFT N/A
- Country
- GTBP United States
- FTFT United States
- Employees
- GTBP N/A
- FTFT N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- GTBP Health Care
- FTFT Consumer Discretionary
- Exchange
- GTBP Nasdaq
- FTFT Nasdaq
- Market Cap
- GTBP 5.5M
- FTFT 5.9M
- IPO Year
- GTBP N/A
- FTFT N/A
- Fundamental
- Price
- GTBP $3.48
- FTFT $1.15
- Analyst Decision
- GTBP Strong Buy
- FTFT
- Analyst Count
- GTBP 1
- FTFT 0
- Target Price
- GTBP $11.00
- FTFT N/A
- AVG Volume (30 Days)
- GTBP 75.0K
- FTFT 48.8K
- Earning Date
- GTBP 08-13-2025
- FTFT 08-18-2025
- Dividend Yield
- GTBP N/A
- FTFT N/A
- EPS Growth
- GTBP N/A
- FTFT N/A
- EPS
- GTBP N/A
- FTFT N/A
- Revenue
- GTBP N/A
- FTFT $2,031,913.00
- Revenue This Year
- GTBP N/A
- FTFT N/A
- Revenue Next Year
- GTBP N/A
- FTFT N/A
- P/E Ratio
- GTBP N/A
- FTFT N/A
- Revenue Growth
- GTBP N/A
- FTFT N/A
- 52 Week Low
- GTBP $1.72
- FTFT $1.01
- 52 Week High
- GTBP $4.10
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- GTBP 76.91
- FTFT 39.32
- Support Level
- GTBP $2.75
- FTFT $1.01
- Resistance Level
- GTBP $3.28
- FTFT $1.16
- Average True Range (ATR)
- GTBP 0.26
- FTFT 0.09
- MACD
- GTBP 0.07
- FTFT 0.01
- Stochastic Oscillator
- GTBP 96.72
- FTFT 25.00
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.